Clinical Trials for Aura Biosciences

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Aura Biosciences

Clinical Trials (4)

NCT06643884
Suprachoroidal Administration in Subjects With Metastases to the Choroid
PHASE2Recruiting
24 participants
Started: Dec 16, 2024 · Completed: Feb 28, 2027
2 conditions1 sponsor9 locations
NCT06007690
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
PHASE3Recruiting
100 participants
Started: Dec 6, 2023 · Completed: Mar 1, 2027
4 conditions1 sponsor63 locations
NCT05483868
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
PHASE1Recruiting
55 participants
Started: Sep 26, 2022 · Completed: Apr 30, 2027
7 conditions1 sponsor10 locations
NCT03941379
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
N/ARecruiting
500 participants
Started: Mar 27, 2019 · Completed: Dec 31, 2029
2 conditions1 sponsor16 locations